STERIS plc (NYSE:STE) Shares Purchased by New York Life Investment Management LLC

New York Life Investment Management LLC boosted its holdings in STERIS plc (NYSE:STE) by 1.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,781 shares of the medical equipment provider’s stock after purchasing an additional 180 shares during the quarter. New York Life Investment Management LLC’s holdings in STERIS were worth $3,038,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Franklin Resources Inc. increased its stake in STERIS by 171.2% in the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock valued at $191,370,000 after purchasing an additional 529,308 shares during the last quarter. Assetmark Inc. increased its stake in STERIS by 24.6% in the third quarter. Assetmark Inc. now owns 13,410 shares of the medical equipment provider’s stock valued at $3,252,000 after purchasing an additional 2,647 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its stake in STERIS by 30.8% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,970 shares of the medical equipment provider’s stock valued at $2,275,000 after purchasing an additional 2,583 shares during the last quarter. KBC Group NV increased its stake in STERIS by 52.0% in the third quarter. KBC Group NV now owns 12,071 shares of the medical equipment provider’s stock valued at $2,928,000 after purchasing an additional 4,132 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new position in STERIS in the third quarter valued at $9,949,000. 94.69% of the stock is currently owned by institutional investors and hedge funds.

STERIS Price Performance

STE stock opened at $219.23 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24. The firm has a market cap of $21.54 billion, a P/E ratio of 46.54 and a beta of 0.84. The stock has a 50-day simple moving average of $214.99 and a 200-day simple moving average of $223.01.

STERIS (NYSE:STE) last posted its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, equities analysts predict that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be paid a $0.57 dividend. The ex-dividend date is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.04%. STERIS’s dividend payout ratio (DPR) is currently 48.41%.

Wall Street Analyst Weigh In

STE has been the subject of several research analyst reports. Stephens restated an “overweight” rating and set a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research note on Friday, November 8th. Piper Sandler upped their price target on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. Finally, JMP Securities restated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research note on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, STERIS currently has an average rating of “Moderate Buy” and a consensus price target of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.